• HOME >
  • IBL News >
  • New Insight: A risk of iatrogenic Alzheimer's disease and cerebral amyloid angiopathy found from research of Creutzfeldt-Jakob disease (CJD)

IBL News

Product News

Product News2015/10/06
New Insight: A risk of iatrogenic Alzheimer's disease and cerebral amyloid angiopathy found from research of Creutzfeldt-Jakob disease (CJD)
The folllowing article publised on Nature that suggests a risk of iatrogenic Alzheimer's disease and cerebral amyloid angiopathy found from research of Creutzfeldt-Jakob disease (CJD).  Our best selling antibody #10323 Anti-Human Amyloidβ (N) (82E1) Mouse IgG MoAb is used in the following article.

Please click the following link to learn more about the study.
Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy. Jaunmuktane Z et al. Nature. 2015 Sep 10;525(7568):247-50. PMID:26354483

Please feel free to contact us with regard to the products.

Immuno-Biological Laboratories Co., Ltd.
Diagnostic Research Reagent Division
Sales Support
TEL: +81-274-50-8666
Email: do-ibl@ibl-japan.co.jp

 
Contact Us >

Return to IBL News Top